Dexcom delivering results
Dexcom has presented promising results from two studies of continuous glucose monitors, including its next-generation G7 CGM, reports Drug Delivery Business. The first study –
Dexcom has presented promising results from two studies of continuous glucose monitors, including its next-generation G7 CGM, reports Drug Delivery Business. The first study –
Shares of Precigen have increased after the company’s Phase 1b/2a study of its AG019 ActoBiotics, designed to address the underlying cause of Type 1 diabetes.
A lower carbohydrate diet is an effective short-term option for adults living with Type 2 diabetes and overweight or obesity, concludes a report by the
Spirit Pharmacy is the UK’s only home delivery pharmacy offering tailored services for people living with diabetes. Their mission is to make accessing advice, education,
NHS Chief Executive Sir Simon Stevens has announced a trial to support the wider roll-out of artificial pancreas technology across England for people with Type
Researchers at King’s College London are looking for older people with Type 2 diabetes or their carers who have recently started insulin treatment to take
A food intelligence company has raised $4m in funding to start shipping its app which scans Abbott’s Freestyle Libre to help people monitor their blood
As reported by Zacks Equity Research in June 2021, Medtronic recently secured two back-to-back European regulatory approvals in the diabetes management space, the first for
People living with Type 2 diabetes are on average waiting more than two years before receiving a diagnosis. There are around 4.8m people living with
This issue is another filled with news and updates with the WHO’s Global Diabetes Compact, the possibility of tarantula venom being used to treat Type